How frequently should a patient taking amiodarone be screened for thyroid dysfunction? (2009)
- Authors:
- USP affiliated authors: MACIEL, LEA MARIA ZANINI - FMRP ; PAZIN FILHO, ANTONIO - FMRP ; MACIEL, BENEDITO CARLOS - FMRP
- Unidade: FMRP
- DOI: 10.1590/s0100-879x2009000800009
- Subjects: DOENÇAS DA TIREOIDE; DOENÇA DE CHAGAS
- Language: Inglês
- Imprenta:
- Publisher place: Ribeirão Preto
- Date published: 2009
- Source:
- Título: Brazilian Journal of Medical and Biological Research
- ISSN: 0100-879X
- Volume/Número/Paginação/Ano: v. 42, n. 8, p. 744-749, 2009
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
PAZIN-FILHO, Antônio et al. How frequently should a patient taking amiodarone be screened for thyroid dysfunction?. Brazilian Journal of Medical and Biological Research, v. 42, n. 8, p. 744-749, 2009Tradução . . Disponível em: https://doi.org/10.1590/s0100-879x2009000800009. Acesso em: 11 fev. 2026. -
APA
Pazin-Filho, A., Jesus, A. M. X. de, Magalhães, P. K. R., Melato, L. H., Campos, D., Maciel, B. C., & Maciel, L. M. Z. (2009). How frequently should a patient taking amiodarone be screened for thyroid dysfunction? Brazilian Journal of Medical and Biological Research, 42( 8), 744-749. doi:10.1590/s0100-879x2009000800009 -
NLM
Pazin-Filho A, Jesus AMX de, Magalhães PKR, Melato LH, Campos D, Maciel BC, Maciel LMZ. How frequently should a patient taking amiodarone be screened for thyroid dysfunction? [Internet]. Brazilian Journal of Medical and Biological Research. 2009 ; 42( 8): 744-749.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1590/s0100-879x2009000800009 -
Vancouver
Pazin-Filho A, Jesus AMX de, Magalhães PKR, Melato LH, Campos D, Maciel BC, Maciel LMZ. How frequently should a patient taking amiodarone be screened for thyroid dysfunction? [Internet]. Brazilian Journal of Medical and Biological Research. 2009 ; 42( 8): 744-749.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1590/s0100-879x2009000800009 - Myocardial ultrasonic tissue characterization in patients with thyroid dysfunction
- Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors
- International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis
- Carotid plaque and intima-media thickness and the incidence of ischemic events in patients with atherosclerotic vascular disease
- Angina and future cardiovascular events in stable patients with coronary artery disease: Insights from the Reduction of Atherothrombosis for Continued Health REACH) Registry
- The reduction of atherothrombosis for continued health (REACH) registry: an international, prespective, observational investigation in subjects at risk for atherothrombotic events-study design
- One-year cardiovascular event rates in outpatients with atherothrombosis
- Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the reduction of atherothrombosis for continued health (REACH) registry
- Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry
- Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis
Informações sobre o DOI: 10.1590/s0100-879x2009000800009 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
001780047.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
